Pyxis Oncology Inc
NASDAQ:PYXS
Income Statement
Earnings Waterfall
Pyxis Oncology Inc
Revenue
|
0
USD
|
Operating Expenses
|
-82.2m
USD
|
Operating Income
|
-82.2m
USD
|
Other Expenses
|
8.4m
USD
|
Net Income
|
-73.8m
USD
|
Income Statement
Pyxis Oncology Inc
Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||
Operating Expenses |
(49)
|
(58)
|
(70)
|
(65)
|
(85)
|
(102)
|
(123)
|
(113)
|
(105)
|
(102)
|
(82)
|
|
Selling, General & Administrative |
(8)
|
(11)
|
(19)
|
(27)
|
(33)
|
(38)
|
(37)
|
(35)
|
(33)
|
(35)
|
(32)
|
|
Research & Development |
(42)
|
(47)
|
(51)
|
(38)
|
(52)
|
(64)
|
(86)
|
(78)
|
(72)
|
(68)
|
(48)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
|
Operating Income |
(49)
N/A
|
(58)
-17%
|
(70)
-20%
|
(65)
+6%
|
(85)
-30%
|
(102)
-20%
|
(123)
-21%
|
(113)
+8%
|
(105)
+7%
|
(102)
+3%
|
(82)
+20%
|
|
Pre-Tax Income | ||||||||||||
Interest Income Expense |
(3)
|
(6)
|
(6)
|
(5)
|
(3)
|
0
|
3
|
4
|
4
|
4
|
2
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
5
|
7
|
|
Pre-Tax Income |
(53)
N/A
|
(64)
-21%
|
(76)
-19%
|
(71)
+7%
|
(88)
-25%
|
(101)
-15%
|
(121)
-19%
|
(109)
+10%
|
(99)
+9%
|
(94)
+5%
|
(74)
+22%
|
|
Net Income | ||||||||||||
Income from Continuing Operations |
(53)
|
(64)
|
(76)
|
(71)
|
(88)
|
(101)
|
(121)
|
(109)
|
(99)
|
(94)
|
(74)
|
|
Net Income (Common) |
(53)
N/A
|
(64)
-21%
|
(76)
-19%
|
(71)
+7%
|
(88)
-25%
|
(101)
-15%
|
(121)
-19%
|
(109)
+10%
|
(99)
+9%
|
(94)
+5%
|
(74)
+22%
|
|
EPS (Diluted) |
-1.61
N/A
|
-1.94
-20%
|
-2.36
-22%
|
-2.2
+7%
|
-2.71
-23%
|
-3.11
-15%
|
-3.65
-17%
|
-3.07
+16%
|
-2.57
+16%
|
-2.28
+11%
|
-1.85
+19%
|